Expansion of somatically reverted memory CD8 + T cells in patients with X-linked lymphoproliferative disease caused by selective pressure from Epstein-Barr virus

Journal of Experimental Medicine

Volumn 209, Issue 5, 2012, Pages 913-924

  Palendira, Umaimainthan ^a,b   Low, Carol ^a   Bell, Andrew I ^c   Ma, Cindy S ^a,b   Abbott, Rachel J M ^c   Phan, Tri Giang ^a,b   Riminton, D Sean ^d   Choo, Sharon ^e   Smart, Joanne M ^e   Lougaris, Vassilios ^f   Giliani, Silvia ^f   Buckley, Rebecca H ^g   Grimbacher, Bodo ^h,m   Alvaro, Frank ⁱ   Klion, Amy D ^j   Nichols, Kim E ^k   Adelstein, Stephen ^l   Rickinson, Alan B ^c   Tangye, Stuart G ^a,b  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d Department of Microbiology and Infectious Diseases   (Australia)

^e ROYAL CHILDREN'S HOSPITAL   (Australia)

^f UNIVERSITY OF BRESCIA   (Italy)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ JOHN HUNTER HOSPITAL   (Australia)

^j NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^k CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^l ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^m UNIVERSITY OF FREIBURG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD45RA ANTIGEN; CHEMOKINE RECEPTOR CCR7; PRIMER DNA; SH2D1A PROTEIN, HUMAN; SIGNAL PEPTIDE;

ARTICLE; B CELL LYMPHOMA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; DISEASE SEVERITY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; EXON; HUMAN; IN VIVO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; MOLECULAR DYNAMICS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVERTANT; SOMATIC REVERSION; X LINKED LYMPHOPROLIFERATIVE DISEASE; AMINO ACID SEQUENCE; DNA SEQUENCE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; VIROLOGY; VIRUS LOAD;

AMINO ACID SEQUENCE; BASE SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; DNA PRIMERS; EXONS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOLOGIC MEMORY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOPROLIFERATIVE DISORDERS; MOLECULAR SEQUENCE DATA; MUTATION; SEQUENCE ANALYSIS, DNA; VIRAL LOAD;

EID: 84863794143     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20112391     Document Type: Article

References (46)

1. Ariga, T., T. Kondoh, K. Yamaguchi, M. Yamada, S. Sasaki, D.L. Nelson, H. Ikeda, K. Kobayashi, H. Moriuchi, and Y. Sakiyama. 2001. Spontaneous in vivo reversion of an inherited mutation in the Wiskott-Aldrich syndrome. J. Immunol. 166:5245-5249.
2. Bar, R.S., C.J. DeLor, K.P. Clausen, P. Hurtubise, W. Henle, and J.F. Hewetson. 1974. Fatal infectious mononucleosis in a family. N. Engl. J. Med. 290:363-367. http://dx.doi.org/10.1056/NEJM197402142900704
3. Betts, M.R., J.M. Brenchley, D.A. Price, S.C. De Rosa, D.C. Douek, M. Roederer, and R.A. Koup. 2003. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods. 281:65-78. http://dx.doi.org/10.1016/ S0022-1759(03)00265-5
4. Booth, C., K.C. Gilmour, P. Veys, A.R. Gennery, M.A. Slatter, H. Chapel, P.T. Heath, C.G. Steward, O. Smith, A. O'Meara, et al. 2011. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease. Blood. 117:53-62. (published erratum appears in Blood. 2011. 118:5060) http://dx.doi.org/10.1182/blood-2010-06-284935
5. Brenchley, J.M., N.J. Karandikar, M.R. Betts, D.R. Ambrozak, B.J. Hill, L.E. Crotty, J.P. Casazza, J. Kuruppu, S.A. Migueles, M. Connors, et al. 2003. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood. 101:2711- 2720. http://dx.doi.org/10.1182/blood-2002-07-2103
6. Cannons, J.L., S.G. Tangye, and P.L. Schwartzberg. 2011. SLAM family receptors and SAP adaptors in immunity. Annu. Rev. Immunol. 29:665- 705. http://dx.doi.org/10.1146/annurev-immunol-030409-101302
7. Chaganti, S., C.S. Ma, A.I. Bell, D. Croom-Carter, A.D. Hislop, S.G. Tangye, and A.B. Rickinson. 2008. Epstein-Barr virus persistence in the absence of conventional memory B cells: IgM+IgD+CD27+ B cells harbor the virus in X-linked lymphoproliferative disease patients. Blood. 112:672-679. http://dx.doi.org/10.1182/blood-2007-10-116269
8. Chen, G., A.K. Tai, M. Lin, F. Chang, C. Terhorst, and B.T. Huber. 2005. Signaling lymphocyte activation molecule-associated protein is a negative regulator of the CD8 T cell response in mice. J. Immunol. 175:2212-2218.
9. Chen, G., A.K. Tai, M. Lin, F. Chang, C. Terhorst, and B.T. Huber. 2007. Increased proliferation of CD8+ T cells in SAP-deficient mice is associated with impaired activation-induced cell death. Eur. J. Immunol. 37:663-674. http://dx.doi.org/10.1002/eji.200636417
10. Coffey, A.J., R.A. Brooksbank, O. Brandau, T. Oohashi, G.R. Howell, J.M. Bye, A.P. Cahn, J. Durham, P. Heath, P. Wray, et al. 1998. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat. Genet. 20:129- 135. http://dx.doi.org/10.1038/2424
11. Dupré, L., G. Andolfi, S.G. Tangye, R. Clementi, F. Locatelli, M. Aricò, A. Aiuti, and M.G. Roncarolo. 2005. SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells. Blood. 105:4383-4389. http://dx.doi.org/10.1182/blood-2004-08-3269
12. Hare, N.J., C.S. Ma, F. Alvaro, K.E. Nichols, and S.G. Tangye. 2006. Missense mutations in SH2D1A identified in patients with X-linked lymphoproliferative disease differentially affect the expression and function of SAP. Int. Immunol. 18:1055-1065. http://dx.doi.org/10.1093/intimm/dxl039
13. Hirschhorn, R. 2003. In vivo reversion to normal of inherited mutations in humans. J. Med. Genet. 40:721-728. http://dx.doi.org/10.1136/ jmg.40.10.721
14. Hirschhorn, R., D.R. Yang, J.M. Puck, M.L. Huie, C.K. Jiang, and L.E. Kurlandsky. 1996. Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency. Nat. Genet. 13:290-295. http://dx.doi.org/10.1038/ng0796-290
15. Hislop, A.D., G.S. Taylor, D. Sauce, and A.B. Rickinson. 2007. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu. Rev. Immunol. 25:587-617. http://dx.doi.org/10.1146/annurev.immunol.25.022106.141553
16. Hislop, A.D., U. Palendira, A.M. Leese, P.D. Arkwright, P.S. Rohrlich, S.G. Tangye, H.B. Gaspar, A.C. Lankester, A. Moretta, and A.B. Rickinson. 2010. Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets. Blood. 116:3249-3257. http://dx.doi.org/ 10.1182/blood-2009-09-238832
17. Jonkman, M.F., and A.M. Pasmooij. 2009. Revertant mosaicism-patchwork in the skin. N. Engl. J. Med. 360:1680-1682. http://dx.doi.org/ 10.1056/NEJMc0809896
18. Junying, J., K. Herrmann, G. Davies, D. Lissauer, A. Bell, J. Timms, G.M. Reynolds, S.G. Hubscher, L.S. Young, G. Niedobitek, and P.G. Murray. 2003. Absence of Epstein-Barr virus DNA in the tumor cells of European hepatocellular carcinoma. Virology. 306:236-243. http:// dx.doi.org/10.1016/S0042-6822(02)00027-2
19. Kalb, R., K. Neveling, H. Hoehn, H. Schneider, Y. Linka, S.D. Batish, C. Hunt, M. Berwick, E. Callen, J. Surralles, et al. 2007. Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype. Am. J. Hum. Genet. 80:895-910. http://dx.doi.org/10.1086/517616
20. Ma, C.S., N.J. Hare, K.E. Nichols, L. Dupré, G. Andolfi, M.G. Roncarolo, S. Adelstein, P.D. Hodgkin, and S.G. Tangye. 2005. Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells. J. Clin. Invest. 115:1049-1059.
21. Ma, C.S., K.E. Nichols, and S.G. Tangye. 2007. Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules. Annu. Rev. Immunol. 25:337-379. http://dx.doi.org/10.1146/ annurev.immunol.25.022106.141651
22. Morra, M., M. Simarro-Grande, M. Martin, A.S. Chen, A. Lanyi, O. Silander, S. Calpe, J. Davis, T. Pawson, M.J. Eck, et al. 2001. Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients. J. Biol. Chem. 276:36809-36816. http://dx.doi.org/10.1074/jbc.M101305200
23. Nichols, K.E., D.P. Harkin, S. Levitz, M. Krainer, K.A. Kolquist, C. Genovese, A. Bernard, M. Ferguson, L. Zuo, E. Snyder, et al. 1998. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc. Natl. Acad. Sci. USA. 95:13765- 13770. http://dx.doi.org/10.1073/pnas.95.23.13765
24. Nichols, K.E., J. Hom, S.Y. Gong, A. Ganguly, C.S. Ma, J.L. Cannons, S.G. Tangye, P.L. Schwartzberg, G.A. Koretzky, and P.L. Stein. 2005a. Regulation of NKT cell development by SAP, the protein defective in XLP. Nat. Med. 11:340-345. http://dx.doi.org/10.1038/nm1189
25. Nichols, K.E., C.S. Ma, J.L. Cannons, P.L. Schwartzberg, and S.G. Tangye. 2005b. Molecular and cellular pathogenesis of X-linked lymphoproliferative disease. Immunol. Rev. 203:180-199. http://dx.doi.org/10.1111/ j.0105-2896.2005.00230.x
26. Nishikomori, R., H. Akutagawa, K. Maruyama, M. Nakata-Hizume, K. Ohmori, K. Mizuno, A. Yachie, T. Yasumi, T. Kusunoki, T. Heike, and T. Nakahata. 2004. X-linked ectodermal dysplasia and immunodeficiency caused by reversion mosaicism of NEMO reveals a critical role for NEMO in human T-cell development and/or survival. Blood. 103:4565-4572. http://dx.doi.org/10.1182/blood-2003-10-3655
27. Palendira, U., C. Low, A. Chan, A.D. Hislop, E. Ho, T.G. Phan, E.K. Deenick, M.C. Cook, D.S. Riminton, S. Choo, et al. 2011. Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP. PLoS Biol. 9:e1001187. http://dx.doi.org/10.1371/journal.pbio.1001187
28. Plunkett, F.J., O. Franzese, L.L. Belaramani, J.M. Fletcher, K.C. Gilmour, R. Sharifi, N. Khan, A.D. Hislop, A. Cara, M. Salmon, et al. 2005. The impact of telomere erosion on memory CD8+ T cells in patients with X-linked lymphoproliferative syndrome. Mech. Ageing Dev. 126:855- 865. http://dx.doi.org/10.1016/j.mad.2005.03.006
29. Puck, J.M., R.L. Nussbaum, and M.E. Conley. 1987. Carrier detection in X-linked severe combined immunodeficiency based on patterns of X chromosome inactivation. J. Clin. Invest. 79:1395-1400. http://dx.doi.org/10.1172/JCI112967
30. Purtilo, D.T., C.K. Cassel, J.P. Yang, and R. Harper. 1975. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet. 305:935-941. http://dx.doi.org/10.1016/S0140-6736(75)92004-8
31. Rieux-Laucat, F., C. Hivroz, A. Lim, V. Mateo, I. Pellier, F. Selz, A. Fischer, and F. Le Deist. 2006. Inherited and somatic CD3zeta mutations in a patient with T-cell deficiency. N. Engl. J. Med. 354:1913-1921. http:// dx.doi.org/10.1056/NEJMoa053750
32. Sallusto, F., D. Lenig, R. Förster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 401:708-712. http://dx.doi.org/ 10.1038/44385
33. Sayos, J., C. Wu, M. Morra, N. Wang, X. Zhang, D. Allen, S. van Schaik, L. Notarangelo, R. Geha, M.G. Roncarolo, et al. 1998. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature. 395:462-469. http://dx.doi.org/10.1038/26683
34. Schwartzberg, P.L., K.L. Mueller, H. Qi, and J.L. Cannons. 2009. SLAM receptors and SAP influence lymphocyte interactions, development and function. Nat. Rev. Immunol. 9:39-46. http://dx.doi.org/10.1038/ nri2456
35. Snow, A.L., R.A. Marsh, S.M. Krummey, P. Roehrs, L.R. Young, K. Zhang, J. van Hoff, D. Dhar, K.E. Nichols, A.H. Filipovich, et al. 2009. Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency. J. Clin. Invest. 119:2976-2989.
36. Speckmann, C., U. Pannicke, E. Wiech, K. Schwarz, P. Fisch, W. Friedrich, T. Niehues, K. Gilmour, K. Buiting, M. Schlesier, et al. 2008. Clinical and immunologic consequences of a somatic reversion in a patient with X-linked severe combined immunodeficiency. Blood. 112:4090-4097. http://dx.doi.org/10.1182/blood-2008-04-153361
37. Stephan, V., V. Wahn, F. Le Deist, U. Dirksen, B. Broker, I. Müller-Fleckenstein, G. Horneff, H. Schroten, A. Fischer, and G. de Saint Basile. 1996. Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells. N. Engl. J. Med. 335:1563-1567. http://dx.doi.org/10.1056/NEJM199611213352104
38. Stewart, D.M., F. Candotti, and D.L. Nelson. 2007. The phenomenon of spontaneous genetic reversions in the Wiskott-Aldrich syndrome: a report of the workshop of the ESID Genetics Working Party at the XIIth Meeting of the European Society for Immunodeficiencies (ESID). Budapest, Hungary October 4-7, 2006. J. Clin. Immunol. 27:634-639. http://dx.doi.org/10.1007/s10875-007-9121-z
39. Sumegi, J., D. Huang, A. Lanyi, J.D. Davis, T.A. Seemayer, A. Maeda, G. Klein, M. Seri, H. Wakiguchi, D.T. Purtilo, and T.G. Gross. 2000. Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Blood. 96:3118-3125.
40. Tone, Y., T. Wada, F. Shibata, T. Toma, Y. Hashida, Y. Kasahara, S. Koizumi, and A. Yachie. 2007. Somatic revertant mosaicism in a patient with leukocyte adhesion deficiency type 1. Blood. 109:1182-1184. http://dx.doi.org/10.1182/blood-2007-08-039057
41. Trifari, S., S. Scaramuzza, M. Catucci, M. Ponzoni, L. Mollica, R. Chiesa, F. Cattaneo, F. Lafouresse, R. Calvez, W. Vermi, et al. 2010. Revertant T lymphocytes in a patient with Wiskott-Aldrich syndrome: analysis of function and distribution in lymphoid organs. J. Allergy Clin. Immunol. 125:439-448: e8. http://dx.doi.org/10.1016/j.jaci.2009.11.034
42. Uzel, G., E. Tng, S.D. Rosenzweig, A.P. Hsu, J.M. Shaw, M.E. Horwitz, G.F. Linton, S.M. Anderson, M.R. Kirby, J.B. Oliveira, et al. 2008. Reversion mutations in patients with leukocyte adhesion deficiency type-1 (LAD-1). Blood. 111:209-218. http://dx.doi.org/10.1182/ blood-2007-04-082552
43. Wada, T., and F. Candotti. 2008. Somatic mosaicism in primary immune deficiencies. Curr. Opin. Allergy Clin. Immunol. 8:510-514. http://dx.doi.org/10.1097/ACI.0b013e328314b651
44. Wada, T., A. Konno, S.H. Schurman, E.K. Garabedian, S.M. Anderson, M. Kirby, D.L. Nelson, and F. Candotti. 2003. Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings. J. Clin. Invest. 111:1389-1397.
45. Wada, T., T. Toma, H. Okamoto, Y. Kasahara, S. Koizumi, K. Agematsu, H. Kimura, A. Shimada, Y. Hayashi, M. Kato, and A. Yachie. 2005. Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency. Blood. 106:2099-2101. http://dx.doi.org/10.1182/blood-2005-03-0936
46. Wehler, T.C., M. Karg, E. Distler, A. Konur, M. Nonn, R.G. Meyer, C. Huber, U.F. Hartwig, and W. Herr. 2008. Rapid identification and sorting of viable virus-reactive CD4(+) and CD8(+) T cells based on antigen-triggered CD137 expression. J. Immunol. Methods. 339:23-37. http://dx.doi.org/10.1016/j.jim.2008.07.017